Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea

PHASE3CompletedINTERVENTIONAL

Enrollment

632

Participants

Timeline

Start Date

March 27, 2014

Primary Completion Date

February 26, 2017

Study Completion Date

March 24, 2017

Conditions

Clostridium Difficile Infection

Interventions

DRUG

Cadazolid

Cadazolid 250 mg as oral suspension twice daily.

DRUG

Vancomycin

Vancomycin 125 mg as oral capsules 4 times daily.

DRUG

Cadazolid-matching placebo

Placebo matching cadazolid and administered orally twice daily

DRUG

Vancomycin-matching placebo

Placebo capsules matching vancomycin and administered orally 4 times per day